Bertrand-Gerentes, Isabelle
Fanchon, Laurent
Coste, Florence
Glover, Richard E.
Guiddir, Tamazoust
Taha, Muhamed-Kheir
Article History
Received: 6 June 2023
Accepted: 1 September 2023
First Online: 26 September 2023
Declarations
:
: I.B-G., L.F., and F.C. are employees of Sanofi and may hold shares and/or stock options in the company. R.E.G. is an employee of inScience Communications, Springer Healthcare Ltd, UK, which was contracted by Sanofi to undertake the literature search and provide editorial assistance. M.K.T. performs contract work for the Institut Pasteur funded by GSK, Pfizer, and Sanofi, and has a patent (NZ630133A) with GSK “vaccines for serogroup X meningococcus” issued.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.